dc.contributor.author | Alkhfify, Donia Mohamed | |
dc.date.accessioned | 2020-07-07T10:06:33Z | |
dc.date.available | 2020-07-07T10:06:33Z | |
dc.date.issued | 2020-02-28 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/1716 | |
dc.description | Asthma is currently understood as a disorder that is characterized by two main
endotypes: type 2 high inflammation and type 2 low inflammation. These subtypes
are broadly defined by their predominant underlying mechanism, which is largely
determined by the T cells or innate lymphocytes and cytokines that are involved. Each
endotype can be further subdivided into multiple phenotypes that are distinguished by
clinical features, pathological findings, and biomarkers (chemokines). Owing to the
lack of uniform criteria for classifying types of asthma 1
, estimates of the prevalence
of type 2 high- and type 2 low-inflammation endotypes vary; however, each endotype
appears to represent approximately half the population with asthma The degree of
inflammation in patients with hypertension and asthma reflects the conjoint effect of
both conditions | en_US |
dc.description.abstract | Asthma and hypertension are common chronic diseases , each with attendant
morbidity, mortality, and economic effects.The presence of hypertension with asthma
creates an additional health burden; hypertension is the world’s most common
modifiable risk factor for cardiovascular disease and death. and the prevalence of
hypertension, like that of asthma, is increasing, along with costs, morbidity, and
mortalityElevated systolic blood pressure was the leading global contributor to
preventable death. In the United States, approximately one in three adults has high
blood pressure., Patients with asthma are more likely to have hypertension than those
who do not, independent of traditional risk factors. A diagnosis of hypertension is
associated with augmented asthma severity, and reduced lung function has been
correlated with heightened cardiovascular mortality.Given the bidirectional
relationship between compromised lung function and compromised cardiovascular
function, the rationale for treating and controlling hypertension in persons with
asthma is compelling. Although the effect of blood-pressure control on asthma is
largely unexplored , and the aim of this report is to discuss the potential mechanistic
links between hypertension and asthma, the influence each condition has on the other,
and approaches to the treatment of hypertension in adult patients with asthma | en_US |
dc.language.iso | en | en_US |
dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | The Relation Between Hypertension and Asthma | en_US |
dc.type | Other | en_US |